FDA rejects MDMA in combination with therapy as treatment for PTSD

go.com

Summary

Lykos Therapeutics, the company that applied for approval, said the treatment is a pharmaceutical version of midomafetamine, better known as MDMA. The FDA requested an additional Phase 3 trial. A panel of independent advisers for the FDA recommended against approval.

pick plectrum plectron rubber eraser rubber pencil eraser thimble ocarina sweet potato-0

8 CommentsShow all comments

froggyweather

Trying to give the benefit of the doubt here: apparently these trials have been going on since the 90s and we are just barely showing any kind of benefit? I'm not surprised they'd still be hesitant to approve it.

theonesourceOP

While true, they keep trying to keep it on schedule 1 when these trials do show medicinal value

FDA rejects MDMA in combination with therapy as treatment for PTSD

Summary

8 CommentsShow all comments

Enjoying SpeakBits?